Preimplantation
genetic diagnosis (PGD) is a state-of-the-art procedure used in conjunction with
in
vitro fertilization
(IVF). PGD
invloves testing an
embryo for certain
conditions prior to
being placed in the womb
of the woman. Under the
direction of Santiago
Munné, Ph.D.,
Director of PGD; and Dr.
Jacques Cohen,
Scientific Director, the
PGD team at the
Institute for
Reproductive Medicine
and Science at Saint
Barnabas (IRMS) is a
world leader in both
research and clinical
application of this
technique.
Your physician may recommend PGD if there is a likelihood
that your embryos will be affected by certain chromosomal conditions. These conditions
can prevent implantation of embryos, lead to pregnancy loss
(miscarriage, recurrent
pregnancy loss) or result in the birth
of a child with physical problems and/or mental retardation.
PGD
can help prevent these adverse outcomes by identifying affected embryos as they are
developing in the laboratory and before they are transferred during
IVF. At this time,
IRMS offers PGD primarily for two specific chromosomal conditions - aneuploidy and
translocations. It is important to note that some of our protocols are experimental
and are supervised by the Internal Review Board of Saint Barnabas Medical Center.
For
specific information
regarding the pgd
procedure see:
